pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,687 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 213 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 14 catalysts2026-07-23: 2 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: recall×clear all
type
  • phase readout4,686
  • 8k filing2,347
  • earnings285
  • pdufa213
  • phase 2 completion172
  • phase 1 completion73
phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›COMPLETEDphase readoutNCT02272361: Trial Comparing Laparoscopic Sacropexy and Vaginal Mesh Surgery for Women Cystocele Repair.

    Sponsor: University Hospital, Lille. Phase: NA. Conditions: Cystocele

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06164561: 18F-FAPI PET/MRI Imaging in Myelofibrosis: a Prospective Observational Study.

    Sponsor: First Affiliated Hospital of Zhejiang University. Phase: . Conditions: Myelofibrosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07038486: Patient Engagement Investigation of NMS Assist

    Sponsor: Newcastle University. Phase: NA. Conditions: Parkinson Disease

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05712278: A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Myeloid Leukemia

    Sponsor: Sanofi. Phase: PHASE1. Conditions: Acute Myeloid Leukaemia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07569978: Efficacy and Safety of High-Concentration 35 kDa Hyaluronan Gel for Herpes Zoster-Associated Pain

    Sponsor: Nakhia Impex LLC. Phase: NA. Conditions: Herpes Zoster, Zoster-Associated Pain, Postherpetic Neuralgia, Neuropathic Pain, Acute Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07515885: Efficacy of Electroacupuncture for Acute Herpes Zoster-Associated Pain and Biomarker Evaluation

    Sponsor: Dexiong Han. Phase: NA. Conditions: Acute Herpes Zoster

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07599943: Population Health Management -Increase Lung Cancer Screening in Community Health Centers (LungSMART)

    Sponsor: University of Utah. Phase: NA. Conditions: Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07360847: Profiling Patients With Rotator Cuff Related Shoulder Pain: What Factors Influence Outcomes With Non-operative Care in a Secondary Care Specialist Shoulder Clinic?

    Sponsor: University of Limerick. Phase: . Conditions: Rotator Cuff Related Shoulder Pain, RCRSP

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07385508: Neurorehabilitation in Patients With Disorders of Consciousness: Multidimensional Ambispective Study on the Impact of Single and Combined Approaches

    Sponsor: IRCCS Centro Neurolesi Bonino Pulejo. Phase: . Conditions: Disorder of Consciousness

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07060508: L9LS in Women of Childbearing Potential in Mali

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE2. Conditions: Malaria

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07428525: A Study to Evaluate AMG 133 in Participants With Varying Degrees of Hepatic Impairment or Normal Hepatic Function

    Sponsor: Amgen. Phase: PHASE1. Conditions: Hepatic Impairment

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07151976: Thrombus Aspiration and Pathology and OCT Study

    Sponsor: Fujita Health University. Phase: . Conditions: Acute Coronary Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06765876: CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial

    Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic. Phase: EARLY_PHASE1. Conditions: Leukemia, Myeloid, Acute(AML), Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic Syndromes (MDS), Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03313817: Pre and Post-arterial Recanalization Imaging of Central Retinal Artery Occlusions (CRAO)

    Sponsor: Fondation Ophtalmologique Adolphe de Rothschild. Phase: . Conditions: Retinal Artery Occlusion, Magnetic Resonance Imaging, Diagnosis, Etiology, Prognosis

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05123040: Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids

    Sponsor: Masonic Cancer Center, University of Minnesota. Phase: PHASE1. Conditions: Acute-graft-versus-host Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07423468: Developing Competency Awareness and Clinical Coordination in a Neonatal Unit

    Sponsor: University of Aarhus. Phase: NA. Conditions: Neonatal Care, Burnout, Professional, Psychological Safety, Interprofessional Relations

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07383168: The Effect of Preoperative Education Delivered Using the Pecha Kucha Method on the Quality of Recovery

    Sponsor: Ankara Yildirim Beyazıt University. Phase: NA. Conditions: Cataract, Education of Patients, Postoperative Recovery

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06116968: An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM

    Sponsor: Corxel Pharmaceuticals. Phase: PHASE3. Conditions: Obstructive Hypertrophic Cardiomyopathy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07015268: A Clinical Study of KLH-2109 in Patients With Endometriosis

    Sponsor: Kissei Pharmaceutical Co., Ltd.. Phase: PHASE3. Conditions: Endometriosis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05617391: An Evaluation of Concordance of Smartwatch ECG and One Clinical ECG and Comparison of The Two ECGS in Terms of Predictive Risks

    Sponsor: St. Jude Children's Research Hospital. Phase: . Conditions: Childhood Cancer, Cardiomyopathy, Primary

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT01977274: Predictive Clinical and Biological Parameters in Gynecological Cancer

    Sponsor: Institut Paoli-Calmettes. Phase: NA. Conditions: Ovarian Cancer, Endometrium Cancer, Cervix Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07151118: ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer

    Sponsor: CHA University. Phase: . Conditions: Biliary Tract Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06008990: Maternal Brain Imaging in Opioid Use Disorder

    Sponsor: Indiana University. Phase: . Conditions: Opioid Use Disorder, Substance-Related Disorders, Substance Use, Pregnancy Related, Narcotic-Related Disorders, Buprenorphine Dependence

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07508410: Comparison of the Eficacy of Mulligan Mobilization and Myofascial Release in Patients With Cervicogenic Headache

    Sponsor: Konya Beyhekim Training and Research Hospital. Phase: NA. Conditions: Cervicogenic Headache

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07614113: Atropine Alone vs Atropine Plus Bifocal Spectacles for Myopia Control in Children

    Sponsor: University of Faisalabad. Phase: NA. Conditions: Myopia, Progressive Myopia, Refractive Errors

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06188520: A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors

    Sponsor: AstraZeneca. Phase: PHASE1. Conditions: ER+ HER2- Advanced Breast Cancer, High-grade Serous Ovarian Cancer (HGSOC)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02851524: Proof of Concept Study Concerning Vestibular Stimulation Using a New Method of Dynamic Posturography.

    Sponsor: Centre Hospitalier Universitaire Dijon. Phase: NA. Conditions: Vestibular Stimulation

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07330882: Health Behavior Management Program for Patients With Coronary Heart Disease

    Sponsor: The First Affiliated Hospital of Bengbu Medical University. Phase: NA. Conditions: Coronary Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05285059: Implicit Learning in Epileptic Children

    Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Epilepsy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07148180: A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax

    Sponsor: Jacqueline Garcia, MD. Phase: PHASE1. Conditions: Acute Myeloid Leukaemia (AML), Leukemia, Blood Cancer, Blood Cancers

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06413979: Family Support Protocol for Adolescent Internalizing Disorders

    Sponsor: The National Center on Addiction and Substance Abuse at Columbia University. Phase: NA. Conditions: Internalizing Disorders, Substance Use Disorders

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07441980: A Clinical Study to Explore the Safety and Efficacy of CT1390B in Relapsed/ Refractory Acute Myeloid Leukemia

    Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE1. Conditions: Relapsed/Refractory Acute Myeloid Leukemia(AML)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06236880: A Phase 2a Study to Evaluate the Safety and Tolerability of GM-2505 in Patients With MDD

    Sponsor: Gilgamesh Pharmaceuticals. Phase: PHASE2. Conditions: Major Depressive Disorder

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07468396: A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer

    Sponsor: Gan & Lee Pharmaceuticals.. Phase: PHASE1. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07474896: Diaphragm-Sparing Regional Anesthesia Techniques for Shoulder Surgery

    Sponsor: Poznan University of Medical Sciences. Phase: NA. Conditions: Osteoarthritis Shoulder

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03357562: MR Imaging of Lung in the Follow-up Assessment of Cystic Fibrosis

    Sponsor: University Hospital, Bordeaux. Phase: NA. Conditions: Cystic Fibrosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07370727: Velocity-Based Resistance Training in Kidney Transplant Recipients

    Sponsor: Fundación Universitaria del Area Andina. Phase: NA. Conditions: Kidney Transplant Recipients, Metabolic Syndrome, Cardiovascular Risk Factors

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06951646: ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)

    Sponsor: Second Xiangya Hospital of Central South University. Phase: PHASE2. Conditions: Non Small Cell Lung Cancer, Immune Checkpoint Inhibitors (ICIs)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT01224288: Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) Scramble

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE3. Conditions: Renal Cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07006727: Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

    Sponsor: Novartis Pharmaceuticals. Phase: PHASE1. Conditions: Small Cell Lung Carcinoma, Large Cell Neuroendocrine Carcinoma of the Lung, Neuroendocrine Prostate Cancer, Gastroenteropancreatic Neuroendocrine Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03747042: Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer

    Sponsor: University of Texas Southwestern Medical Center. Phase: PHASE2. Conditions: Breast Cancer Female

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06016686: Microelectrode Recordings From the Vagus Nerve in Awake Humans

    Sponsor: University of Minnesota. Phase: PHASE1. Conditions: Epilepsy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04205370: Sleep Behaviors in Pregnancy

    Sponsor: University of Michigan. Phase: NA. Conditions: Sleep, Pregnancy Complications

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07390370: Establishment of a Registry for Immediate Drug Allergy

    Sponsor: Yonsei University. Phase: . Conditions: Drug Hypersensitivity

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07472270: Safety Evaluation of MSC-based Therapy for Liver Cihcrosis Treatment

    Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology. Phase: PHASE1. Conditions: Liver Cirrhosis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05805501: A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma

    Sponsor: Hoffmann-La Roche. Phase: PHASE2. Conditions: Renal Cell Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02248519: Laparoscopic Versus Open Gastrectomy for Gastric Cancer

    Sponsor: UMC Utrecht. Phase: NA. Conditions: Gastric Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07556419: Developing a Mobile App for Patients With Hypertension

    Sponsor: Kafkas University. Phase: NA. Conditions: Hypertension, Mobile Application, Blood Pressure Control, Treatment Adherence, Self-Efficacy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06401928: Electrical Brain Stimulation for Treatment of Secondary Symptoms in Multiple Sclerosis

    Sponsor: The National Brain Mapping Laboratory (NBML). Phase: NA. Conditions: Multiple Sclerosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06693765: A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Participants With Severe Renal Impairment, End-stage Kidney Disease, and in Healthy Participants

    Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Renal Impairment, End-stage Kidney Disease, Healthy Participants

    full page →ctgov ↗
    ← prev
    page 58 of 94
    next →